DRIVERS OF REVERSE LOGISTICS AND CAPABILITIES ON OPERATIONAL PERFORMANCE: WITH SPECIAL REFERENCE TO PHARMACEUTICAL INDUSTRY

Show simple item record

dc.contributor.author Pananwala, P.A.S.P.
dc.contributor.author Galahitiyawe, N.W.
dc.contributor.author Chamara, D.D.I.
dc.contributor.author Abeywardhana, H.M.D.S.
dc.date.accessioned 2025-03-16T10:16:25Z
dc.date.available 2025-03-16T10:16:25Z
dc.date.issued 2024-11-28
dc.identifier.citation 3rd International Research Symposium on Management en_US
dc.identifier.issn 2651-0006
dc.identifier.uri http://repository.rjt.ac.lk/handle/123456789/7227
dc.description.abstract Reverse logistics has seen rapid growth owing to an increase in production and consumption activities. This practice plays a crucial role, particularly when products remain on the market beyond their expiration date, which can lead to significant issues. The pharmaceutical industry is one such industry in which it is important to properly dispose of recalled and expired drugs. Consequently, there is increasing concern regarding how pharmaceutical products are managed in the market when they are damaged or reach the end of their lives. Reverse logistics, sometimes referred to as “product-take-back,” is viewed as one of the concepts within the broader framework of green supply chain management that can address this problem. Moreover, regulatory bodies are increasingly pressurizing companies to become more environmentally responsible for producing and managing their products. Hence, businesses have begun to recognize the need to incorporate environmental responsibility into their activities. Reverse logistics is a sustainable supply chain strategy that allows firms to manage waste efficiently, while enhancing their operational performance by integrating sustainability. This study examines the influence of reverse logistics drivers on operational performance through the development of reverse logistics capabilities with a focus on pharmaceutical companies. This research was conducted among a population of 20 pharmaceutical companies approved by the National Medical Regulatory Authority in Sri Lanka, from which a sample of 254 executive-level employees was selected through convenience sampling. Data were collected using a pre-tested questionnaire, and the analysis was conducted using Structural Equation Modeling with AMOS 20.0, and SPSS version 20.0. The findings revealed that reverse logistics drivers alone do not have a significant direct impact on operational performance according to the structural model. However, when reverse logistics capabilities serve as mediators, the relationship between drivers and performance becomes significant. This suggests that building strong reverse logistics capabilities is essential to maximize the positive impact of reverse logistics drivers on operational performance. It is recommended that top management focus on increasing awareness of the importance of these capabilities to harness reverse logistics drivers and improve organizational performance. en_US
dc.language.iso en en_US
dc.publisher Faculty of Management, Rajarata University of Sri Lanka en_US
dc.subject Green supply chain management en_US
dc.subject operational performance en_US
dc.subject reverse logistics en_US
dc.subject reverse logistics capabilities en_US
dc.subject reverse logistics drivers en_US
dc.title DRIVERS OF REVERSE LOGISTICS AND CAPABILITIES ON OPERATIONAL PERFORMANCE: WITH SPECIAL REFERENCE TO PHARMACEUTICAL INDUSTRY en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search RUSL-IR


Browse

My Account